CytomX About Probody Therapeutics Pipeline Partners Investors & News Culture & Careers Pioneering potentially life-changing conditionally activated therapeutics Advancing a Pipeline Our expanding pipeline of Probody® therapeutics is built on a robust portfolio of proprietary and patented technology. Rooted in innovation and differentiation, and driven by our vision and mission, we are advancing a deep oncology pipeline of Probody therapeutics by blazing our own trail and in partnership with some of the world’s leading biopharmaceutical companies. Contact Us 151 Oyster Point Blvd, Suite 400 South San Francisco, CA 94080-1913 Offices: 650-515-3185 Fax: 650-351-0353 Share Linkedin Twitter © 2021 CytomX Therapeutics, Inc. | PROBODY, CYTOMX, and our corporate logo are U.S. registered trademarks of CytomX Therapeutics, Inc. IHZ is a trademark of CytomX Therapeutics, Inc. All other brands and trademarks referenced herein are the property of their respective owners. About Overview Vision & Mission Our Values Executive Team Board of Directors Scientific Advisory Board Contact Us Probody Therapeutics Our Probody Approach How Probody Therapeutics Work A Versatile Platform Scientific Publications & Presentations Pipeline Advancing a Pipeline Lead Candidates Clinical Trials Access for HCPs/Patients Partners Opportunities Current Partners Investors & News Corporate Profile Press Releases Events & Presentations Scientific Publications Corporate Governance Stock Information Financial & Filings Analyst Coverage Investor Resources Culture & Careers Overview Xtraordinary Culture Current Openings Total Rewards Program Corporate Amenities Home Terms of use Privacy policy Disclaimer for Twitter